CIK 0000894158
- Non-accelerated filer
- Smaller reporting company
Theriva Biologics, Inc.
Sign in to watch- Ticker
- TOVX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 133808303
- Phone
- +1 734-332-7800
- Business address
- 9605 MEDICAL CENTER DRIVE, SUITE 270, ROCKVILLE, MD, 20850
- Former names
- Synthetic Biologics, Inc., ADEONA PHARMACEUTICALS, INC., PIPEX PHARMACEUTICALS, INC., SHEFFIELD PHARMACEUTICALS INC, SHEFFIELD MEDICAL TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2007-11-09 | Ridgeback Capital Investments Ltd. 10% owner | Option exercise · Warrants (right to buy) | −618,855 | 0 | ||
| 2007-11-09 | DORMAN DANIEL J Director | Purchase | +6,189 | $2.22 | $14K | 18,566 |
| 2007-11-09 | DORMAN DANIEL J Director | Purchase | +247,542 | $2.22 | $550K | 742,626 |
| 2007-11-09 | DORMAN DANIEL J Director | Option exercise · Warrants | +6,189 | 0 | ||
| 2007-11-09 | DORMAN DANIEL J Director | Option exercise · Warrants | +247,542 | 0 | ||
| 2007-11-02 | Kraws Jeffrey J Director | Grant or award · Stock Options | +8,333 | 237,106 | ||
| 2007-11-02 | Newsome David A. Chief Scientific Officer | Grant or award · Stock Options | +150,000 | 150,000 | ||
| 2007-11-02 | KUO JAMES S Director | Grant or award · Stock Options | +8,333 | 33,333 | ||
| 2007-11-02 | DORMAN DANIEL J Director | Grant or award · Stock Options | +8,333 | 33,333 | ||
| 2007-11-02 | Wolf Jeffrey Alan Director | Grant or award · Stock Options | +8,333 | 33,333 | ||
| 2007-07-25 | KANZER STEVE H CEO | Purchase | +5,000 | $7.42 | $37K | 315,946 |
| 2007-07-25 | KANZER STEVE H CEO | Purchase | +200 | $7.16 | $1K | 316,146 |
| 2007-07-25 | KANZER STEVE H CEO | Purchase | +2,100 | $7.15 | $15K | 318,246 |
| 2007-07-25 | KANZER STEVE H CEO | Purchase | +2,000 | $7.14 | $14K | 320,246 |
| 2007-07-25 | KANZER STEVE H CEO | Purchase | +5,000 | $7.09 | $35K | 325,246 |
| 2007-07-24 | KANZER STEVE H CEO | Purchase | +1,300 | $7.24 | $9K | 304,246 |
| 2007-07-24 | KANZER STEVE H CEO | Purchase | +1,700 | $7.17 | $12K | 305,946 |
| 2007-07-24 | KANZER STEVE H CEO | Purchase | +1,000 | $7.13 | $7K | 306,946 |
| 2007-07-24 | KANZER STEVE H CEO | Purchase | +2,400 | $7.11 | $17K | 309,346 |
| 2007-07-24 | KANZER STEVE H CEO | Purchase | +300 | $7.10 | $2K | 309,646 |
Page 8 of 15 · 290 trades